Double signal stimulation was required for full recovery of the autologous tumor-killing effect of effusion-associated lymphocytes

被引:10
作者
Chen, YM
Tsai, CM
Whang-Peng, J
Perng, RP
机构
[1] Taipei Vet Gen Hosp, Chest Dept, Taipei, Taiwan
[2] Natl Hlth Res Inst, Div Canc Res, Taipei 112, Taiwan
关键词
interferon-gamma; interleukin-7; interleukin-12; lymphocyte function; malignant pleural effusion;
D O I
10.1378/chest.122.4.1421
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objectives: To determine the different effects of interleukin (IL)-2, IL-4, IL-7, IL-10, IL-12, and/or T-cell receptor (TCR)-CD3 engagement in recovering the functions of cytotoxic T lymphocytes (CTL) from malignant effusion. Setting: National teaching hospital. Materials and methods: Effusion-associated lymphocytes (EAL) were isolated from 35 malignant pleural effusions. Interferon (IFN)-gamma production, proliferative response, and cytolytic activity of the cultured EAL against autologous tumors and K-562 cells were measured. Results: It was found that EAL had a significantly depressed function. Stimulation with two signals, including IL-2 plus IL-7, IL-2 plus IL-12, or IL-2 plus TCR-CD3 engagement, could fully restore the functions of EAL, including IFN-gamma production, proliferative response, and a specific increase in cytolytic activity against autologous tumor cells. IL-4 and IL-10, whether or not in combination with IL-2, did not augment the function of EAL, and even depressed it in some cases. The lymphocyte-depletion test showed that most of the recovered functions were from CD8(+) CTL. Conclusion: The depressed cellular function of EAL could be reversed with double signal stimulation, including IL-2 plus IL-7, IL-2 plus IL-12, or IL-2 plus TCR-CD3 engagement. These recovered cellular functions were mainly from CDS+ CTL.
引用
收藏
页码:1421 / 1427
页数:7
相关论文
共 15 条
[1]   INTERLEUKIN-7 ENHANCES CYTOLYTIC LYMPHOCYTE-T GENERATION AND INDUCES LYMPHOKINE-ACTIVATED KILLER-CELLS FROM HUMAN PERIPHERAL-BLOOD [J].
ALDERSON, MR ;
SASSENFELD, HM ;
WIDMER, MB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (02) :577-587
[2]   Cross regulation by IL-10 and 1L-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients [J].
Chen, YM ;
Yang, WK ;
Ting, CC ;
Tsai, WY ;
Yang, DM ;
WhangPeng, J ;
Perng, RP .
CHEST, 1997, 112 (04) :960-966
[3]   Restoration of the immunocompetence by IL-2 activation and TCR-CD3 engagement of the in vivo anergized tumor-specific CTL from lung cancer patients [J].
Chen, YM ;
Yang, WK ;
WhangPeng, J ;
Tsai, WY ;
Hung, YM ;
Yang, DM ;
Lin, WC ;
Perng, RP ;
Ting, CC .
JOURNAL OF IMMUNOTHERAPY, 1997, 20 (05) :354-364
[4]   Elevation of interleukin-10 levels in malignant pleural effusion [J].
Chen, YM ;
Yang, WK ;
WhangPeng, J ;
Kuo, BIT ;
Perng, RP .
CHEST, 1996, 110 (02) :433-436
[5]  
Cheng YX, 2001, CHIN J STRUCT CHEM, V20, P31
[6]   INTERLEUKIN-7 GENERATES ANTITUMOR CYTOTOXIC LYMPHOCYTES-T AGAINST MURINE SARCOMAS WITH EFFICACY IN CELLULAR ADOPTIVE IMMUNOTHERAPY [J].
JICHA, DL ;
MULE, JJ ;
ROSENBERG, SA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (06) :1511-1515
[7]   MONOCLONAL ANTIBODIES DEFINING DISTINCTIVE HUMAN T-CELL SURFACE-ANTIGENS [J].
KUNG, PC ;
GOLDSTEIN, G ;
REINHERZ, EL ;
SCHLOSSMAN, SF .
SCIENCE, 1979, 206 (4416) :347-349
[8]  
Mackensen Andreas, 1997, Cytokine and Growth Factor Reviews, V8, P119, DOI 10.1016/S1359-6101(96)00052-4
[9]   INTERLEUKIN-10 IS A POTENT INHIBITOR OF TUMOR-CYTOTOXICITY BY HUMAN MONOCYTES AND ALVEOLAR MACROPHAGES [J].
NABIOULLIN, R ;
SONE, S ;
MIZUNO, K ;
YANO, S ;
NISHIOKA, Y ;
HAKU, T ;
OGURA, T .
JOURNAL OF LEUKOCYTE BIOLOGY, 1994, 55 (04) :437-442
[10]   Interleukin-10: a cytokine used by tumors to escape immunosurveillance [J].
Salazar-Onfray, F .
MEDICAL ONCOLOGY, 1999, 16 (02) :86-94